Overseeing the implementation of the EU medical device directives: EMA or CMC?
This article was originally published in RAJ Devices
As 2010 draws to an end, the medical devices sector is preparing to take a breather before throwing itself back into what promises to be a year of intense debate over the exact future of medical device legislation in the EU and its impact on the industry.
You may also be interested in...
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies